首页 | 本学科首页   官方微博 | 高级检索  
     

肺癌患者血浆及外周血单个核细胞Lunx mRNA检测的临床意义
引用本文:赵文杰,周洪兴,王苏建,吴建康,王家平,张平. 肺癌患者血浆及外周血单个核细胞Lunx mRNA检测的临床意义[J]. 检验医学, 2012, 27(8): 631-634
作者姓名:赵文杰  周洪兴  王苏建  吴建康  王家平  张平
作者单位:南京医科大学附属常州市第二人民医院检验科,江苏,常州,213003
摘    要:目的检测肺癌患者血浆及外周血单个核细胞肺特异性X基因(Lunx)mRNA,探讨两者对肺癌辅助诊断的临床意义。方法采用荧光定量聚合酶链反应(PCR)检测肺癌患者、肺良性疾病患者、肺外肿瘤患者及健康人血浆及外周血单个核细胞Lunx mRNA。结果肺癌组患者血浆Lunx mRNA阳性率显著高于肺良性疾病组(χ2=113.10,P<0.01)、肺外肿瘤组(χ2=125.34,P<0.01)和健康组(χ2=100.33,P<0.01);Ⅲ~Ⅳ期肺癌患者血浆Lunx mRNA阳性率高于Ⅰ、Ⅱ期肺癌患者(χ2=7.07,P<0.05)。肺癌组患者外周血单个核细胞LunxmRNA阳性率显著高于肺良性疾病组(χ2=32.79,P<0.01)、肺外肿瘤组(χ2=44.44,P<0.01)和健康组(χ2=44.44,P<0.01);Ⅲ~Ⅳ期肺癌患者外周血单个核细胞Lunx mRNA阳性率显著高于Ⅰ、Ⅱ期肺癌患者(χ2=24.52,P<0.01)。血浆Lunx mRNA检测对肺癌辅助诊断的敏感性高于单个核细胞检测的敏感性(χ2=36.46,P<0.01),血浆检测的阴性预测值高于外周血单个核细胞检测的阴性预测值(χ2=16.37,P<0.01)。结论血浆与外周血单个核细胞Lunx mRNA检测均可用于肺癌的辅助诊断,前者敏感性较后者高。

关 键 词:肺特异性X基因  循环RNA  循环肿瘤细胞  聚合酶链反应  肺癌

The clinical significance of Lunx mRNA detection in plasma and peripheral mononuclear cells in patients with lung cancer
ZHAO Wenjie , ZHOU Hongxing , WANG Sujian , WU Jiankang , WANG Jiaping , ZHANG Ping. The clinical significance of Lunx mRNA detection in plasma and peripheral mononuclear cells in patients with lung cancer[J]. Laboratory Medicine, 2012, 27(8): 631-634
Authors:ZHAO Wenjie    ZHOU Hongxing    WANG Sujian    WU Jiankang    WANG Jiaping    ZHANG Ping
Affiliation:.(Department of Clinical Laboratory,Changzhou Second People′s Hospital,Nanjing Medical University,Jiangsu Changzhou 213003,China)
Abstract:Objective To investigate the clinical auxiliary diagnosis significance of lung-specific X gene(Lunx) mRNA detection in plasma and peripheral mononuclear cells in patients with lung cancer.Methods Lunx mRNA in plasma and peripheral mononuclear cells was detected by fluorescence quantitation polymerase chain reaction(PCR) in patients with lung cancer,benign lung disease,extrapulmonary tumor and healthy subjects.Results The positive rate of Lunx mRNA from plasma in lung cancer group was significantly higher than those in benign lung disease group(χ2=113.10,P〈0.01),extrapulmonary tumor group(χ2=125.34,P〈0.01) and healthy subjects(χ2=100.33,P〈0.01).The positive rate of Lunx mRNA in plasma in patients with Ⅲ-Ⅳ stages of lung cancer was significantly higher than that in patients with Ⅰ-Ⅱ stages of lung cancer(χ2=7.07,P〈0.05).The positive rate of Lunx mRNA in peripheral mononuclear cells in lung cancer group was significantly higher than those in benign lung disease group(χ2=32.79,P〈0.01),extrapulmonary tumor group(χ2=44.44,P〈0.01) and healthy subjects(χ2=44.44,P〈0.01).The positive rate of Lunx mRNA in peripheral mononuclear cells in patients with Ⅲ-Ⅳ stages of lung cancer was significantly higher than that in patients with Ⅰ-Ⅱ stages of lung cancer(χ2=24.52,P〈0.01).For the auxiliary diagnosis of lung cancer,the sensitivity of Lunx mRNA detection in plasma was higher than that in mononuclear cells(χ2=36.46,P〈0.01).The negative predictive value of the Lunx mRNA detection in plasma was higher than that in mononuclear cells(χ2=16.37,P〈0.01).Conclusions The detection of Lunx mRNA in plasma and peripheral mononuclear cells can be used for the auxiliary diagnosis of lung cancer.The sensitivity in plasma is higher than that in mononuclear cells.
Keywords:Lung-specific X gene; Circulating RNA; Circulating tumor cell; Polymerase chain reaction; Lung cancer
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号